Questions on variant Creutzfeldt–Jakob disease and blood transfusion
Two developments in the field of variant Creutzfeldt–Jakob disease (vCJD) occurred in 2009. In order to address a number of questions that were raised, ECDC internal and external experts prepared this risk assessment. The document focuses on how these new facts affect the current assumptions regarding transmissibility of the disease through blood transfusion and tissue/cells transplantation.
Rapid risk assessment: Dengue outbreak in Réunion, France, and associated risk of autochthonous outbreak in the EU/EEA
18 Jun 2019 - This update of the risk assessment ‘Dengue outbreak in Réunion, France’ published on 5 July 2018, has been triggered by the significant size of the outbreak and its expected duration, which is anticipated to overlap with high vector activity in the southern EU.
Rapid risk assessment: Chlamydia trachomatis false-negative test results by Aptima Combo 2 CT/NG assay (Hologic) in the EU/EEA, 2019
17 Jun 2019 - In April 2019, Finland reported false-negative or equivocal results in patients tested for Chlamydia trachomatis (CT) using Aptima Combo 2 Assay (Hologic) (AC2).
Multi-country outbreak of Listeria monocytogenes clonal complex 8 infections linked to consumption of cold-smoked fish products
4 Jun 2019 - This joint ECDC-EFSA rapid outbreak assessment provides an assessment of the cross-border public health risk related to L. monocytogenes infections linked to the consumption of cold-smoked fish products, possibly originating from a single food processing company.